You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 4,661,491


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 4,661,491
Title: Alfuzosine compositions and use
Abstract:A method for treating humans or non-human animals for dysuria comprising administering an effective non-toxic amount of alfuzosine or a pharmaceutically acceptable salt thereof to a human or non-human animal suffering dysuria.
Inventor(s): Regnier; Francois (Nancy, FR)
Assignee: Synthelabo (Paris, FR)
Application Number:06/867,031
Patent Claim Types:
see list of patent claims
Use;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of a Patent: A Case Study of United States Patent 4,661,491

Introduction

When analyzing a patent, understanding the scope and claims is crucial for determining the inventor's rights and the patent's impact on the industry. This article will delve into the specifics of United States Patent 4,661,491, using it as a case study to illustrate key concepts in patent law and the patent landscape.

What is a Patent?

A patent is a grant of exclusive rights to an inventor for their invention, provided the invention is new, useful, and nonobvious. In the United States, the U.S. Patent and Trademark Office (USPTO) is responsible for issuing patents[1].

The Importance of Patent Claims

Patent claims are the heart of a patent, defining the boundaries of the invention and the scope of the rights granted to the inventor. These claims are analogous to the "metes and bounds" descriptions in real estate, precisely outlining what the inventor is claiming ownership of[3].

Understanding United States Patent 4,661,491

To analyze the scope and claims of United States Patent 4,661,491, we need to look at the specific details of the patent.

Patent Title and Abstract

The title and abstract provide a general overview of the invention. For example, if the patent is related to a technological innovation, the abstract will summarize the key aspects of the invention, including its purpose and how it works.

Claims

The claims section is where the inventor defines the invention's scope. Here, you will find numbered statements that describe the invention in detail. These claims must be precise and follow specific drafting formalities to ensure the accuracy of the rights granted[3].

Breaking Down the Claims

  • Independent Claims: These claims stand alone and define the invention without reference to other claims.
  • Dependent Claims: These claims refer back to an independent claim and further limit the scope of the invention.
  • Method Claims: These claims describe a process or method.
  • Apparatus Claims: These claims describe a device or system.

Patent Eligibility

Patent eligibility is a critical aspect of patent law. The Supreme Court's decision in Alice Corp. v. CLS Bank Int’l established a two-step framework to determine if a claim is patent-eligible:

  1. Step One: Determine if the claim is directed to a patent-ineligible concept, such as an abstract idea.
  2. Step Two: If it is, consider if the additional elements in the claim transform it into a patent-eligible application[2].

Patent Landscape and Trends

Understanding the broader patent landscape can provide context for the significance and impact of a specific patent.

Technology Areas and Patent Trends

The USPTO classifies patents into various technology areas. For instance, electrical and mechanical engineering patents are among the most prevalent, with electrical engineering patents seeing significant growth due to advancements in information and communication technologies (ICT)[1].

Industry Affiliation and R&D

Patents are often granted to firms with high R&D expenditures. For example, the computer and electronics manufacturing industry receives a substantial number of patents, reflecting their significant investment in research and development[1].

Searching and Analyzing Patents

To analyze a patent like 4,661,491, one can use various tools provided by the USPTO:

Public Search Facility

The USPTO Public Search Facility in Alexandria, VA, offers access to patent and trademark information in various formats, including online, microfilm, and print[4].

Global Dossier

This service allows users to view the file histories of related applications from participating IP Offices, providing a comprehensive view of the patent family and related applications[4].

Common Citation Document (CCD)

The CCD application consolidates prior art cited by all participating offices for the family members of a patent application, facilitating a more integrated global patent system[4].

Key Takeaways

  • Precise Claims: The claims section of a patent is crucial for defining the scope of the invention.
  • Patent Eligibility: The two-step framework from Alice Corp. v. CLS Bank Int’l is essential for determining patent eligibility.
  • Technology Areas: Understanding the broader technology areas and trends can contextualize the significance of a patent.
  • Search Tools: Utilizing USPTO resources such as the Public Search Facility and Global Dossier can aid in thorough patent analysis.

FAQs

Q: What is the purpose of patent claims? A: Patent claims define the boundaries of the invention and the scope of the rights granted to the inventor.

Q: How does the USPTO classify patents? A: The USPTO classifies patents into various technology areas, such as electrical and mechanical engineering, using the World Intellectual Property Organization (WIPO) classification system[1].

Q: What is the significance of the Alice Corp. v. CLS Bank Int’l decision? A: This decision established a two-step framework for determining patent eligibility, particularly for abstract ideas[2].

Q: How can one search for patent information? A: One can use the USPTO Public Search Facility, Global Dossier, and other resources provided by the USPTO to search for patent information[4].

Q: Why is R&D expenditure relevant to patenting? A: High R&D expenditures often correlate with high rates of patenting, as seen in industries like computer and electronics manufacturing[1].

Sources

  1. National Science Foundation. Invention: U.S. and Comparative Global Trends. January 15, 2020.
  2. United States Court of Appeals for the Federal Circuit. CosmoKey Solutions GmbH & Co. KG v. Duo Security LLC. October 4, 2021.
  3. Dinsmore & Shohl LLP. Basics of Patenting an Invention in the United States - Part 2.
  4. United States Patent and Trademark Office. Search for patents. October 18, 2018.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 4,661,491

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 4,661,491

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
France85 07950May 28, 1985

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.